The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 7,387 | 525,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| AVEXIS INC | COM | 05366U100 | 65,728 | 800,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| BARCLAYS BK PLC | IPATH S&P 500 VIX | 06740Q252 | 3,190 | 250,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 27,000 | 600,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| BELLEROPON THERAPEUTICS INC | COM | 078771102 | 2,489 | 1,857,143 | SH | OTR | 1 | 0 | 0 | 0 | |
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 12,668 | 250,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| CLOVIS ONCOLOGY INC | COM | 189464100 | 46,815 | 500,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 2,448 | 425,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 1,093 | 138,331 | SH | OTR | 1 | 0 | 0 | 0 | |
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 46,280 | 1,000,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| G1 THERAPEUTICS INC | COM | 3621LQ109 | 10,973 | 629,179 | SH | OTR | 1 | 0 | 0 | 0 | |
| INCYTE CORP | COM | 45337C102 | 12,591 | 100,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| KURA ONCOLOGY INC | COM | 50127T109 | 4,959 | 533,251 | SH | OTR | 1 | 0 | 0 | 0 | |
| LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459604 | 7,963 | 267,500 | SH | OTR | 1 | 0 | 0 | 0 | |
| MACROGENICS INC | COM | 556099109 | 37,034 | 2,115,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| MEDICINES COMPANY | COM | 584688105 | 46,182 | 1,215,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| MEDICINES COMPANY | CALL | 584688905 | 20,168 | 530,600 | SH | Call | OTR | 1 | 0 | 0 | 0 |
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 3,789 | 1,037,994 | SH | OTR | 1 | 0 | 0 | 0 | |
| NABRIVA THERAPEUTICS AG | SPONSORED ADR | 62957M104 | 1,852 | 176,710 | SH | OTR | 1 | 0 | 0 | 0 | |
| ONCONOVA THERAPEUTICS INC | *W EXP 07/11/202 | 68232V116 | 109 | 241,644 | SH | OTR | 1 | 0 | 0 | 0 | |
| ONCONOVA THERAPEUTICS INC | COM NEW | 68232V306 | 654 | 302,886 | SH | OTR | 1 | 0 | 0 | 0 | |
| PTC THERAPEUTICS INC | COM | 69366J200 | 31,161 | 1,700,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 8,740 | 100,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| SEATTLE GENETICS INC | COM | 812578102 | 6,468 | 125,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 6,721 | 940,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 2,768 | 1,025,000 | SH | OTR | 1 | 0 | 0 | 0 | |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,272 | 234,220 | SH | OTR | 1 | 0 | 0 | 0 | |